NCT02490436View on ClinicalTrials.gov

Novel Treatment Option for Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
NeuralgiaComplex Regional Pain Syndromes
Interventions
DRUG

Cetuximab

Randomized cross-over between cetuximab and placebo

DRUG

Placebo

Randomized cross-over between cetuximab and placebo

Trial Locations (1)

4604

Center for Cancer Treatment, Sorlandet Hospital HF, Kristiansand

All Listed Sponsors
collaborator

Frontier Science & Technology Research Foundation, Inc.

INDUSTRY

collaborator

Merck KGaA, Darmstadt, Germany

INDUSTRY

lead

Sorlandet Hospital HF

OTHER_GOV

NCT02490436 - Novel Treatment Option for Neuropathic Pain | Biotech Hunter | Biotech Hunter